Document is current
Any future updates will be listed below
-
Authors
Lu, Yuancheng Ryan https://orcid.org/0000-0002-5982-3963
Tian, Xiao https://orcid.org/0000-0001-5300-3596
Sinclair, David A. https://orcid.org/0000-0002-9936-436X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG019719)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (K99AG068303)
- License Information
-
More Information
Article History
Received: 28 April 2022
Accepted: 2 October 2023
First Online: 15 December 2023
Competing interests
: Y.R.L., D.A.S. and X.T. are inventors on patent applications licensed to Life Biosciences, a company developing epigenetic reprogramming-based therapies, in which Y.R.L. and D.A.S. have equity. Complete details of all relationships for profit and not-for-profit for D.A.S. can be found in the Supplementary Information.
